- Public Comps
- China-Singapore Suzhou
China-Singapore Suzhou Valuation Multiples
Discover China-Singapore Suzhou's revenue and EBITDA valuation multiples and investment history, alongside public comparables like GIMV, Kinnevik, Georgia Capital, Antin Infrastructure Partners and more.
China-Singapore Suzhou Overview
About China-Singapore Suzhou
China-Singapore Suzhou Industrial Park Development Group Co Ltd is engaged in development and construction for the Suzhou Industrial Park. The company through its subsidiaries, focuses on the construction, investment promotion and operation of the district's parks. It has implemented park development and operation projects in Anhui, Zhejiang, Ningxia and other places.
Founded
2008
HQ

Employees
N/A
Website
Sectors
Financials (LTM)
EV
$3.5B
Valuation Multiples
Start free trialChina-Singapore Suzhou Financials
China-Singapore Suzhou reported last 12-month revenue of $472M and EBITDA of $284M.
In the same LTM period, China-Singapore Suzhou generated $209M in gross profit, $284M in EBITDA, and $155M in net income.
China-Singapore Suzhou P&L
In the most recent fiscal year, China-Singapore Suzhou reported revenue of $479M and EBITDA of $331M.
China-Singapore Suzhou is profitable as of last fiscal year, with gross margin of 44%, EBITDA margin of 69%, and net margin of 33%.
Financial data powered by Morningstar, Inc.
China-Singapore Suzhou Stock Performance
China-Singapore Suzhou has current market cap of $1.9B, and enterprise value of $3.5B.
China-Singapore Suzhou's stock price is $1.28.
China-Singapore Suzhou has an EPS (earnings per share) of $0.10.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3.5B | $1.9B | 0.5% | - | - | - | $0.10 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialChina-Singapore Suzhou Valuation Multiples
China-Singapore Suzhou trades at 7.4x EV/Revenue multiple, and 12.3x EV/EBITDA.
China-Singapore Suzhou Financial Valuation Multiples
As of September 5, 2026, China-Singapore Suzhou has market cap of $1.9B and EV of $3.5B.
China-Singapore Suzhou has a P/E ratio of 12.4x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified China-Singapore Suzhou Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


China-Singapore Suzhou Margins & Growth Rates
China-Singapore Suzhou grew revenue by 12% but EBITDA decreased by 6% in the last fiscal year.
In the most recent fiscal year, China-Singapore Suzhou reported gross margin of 44%, EBITDA margin of 69%, and net margin of 33%.
China-Singapore Suzhou Margins
China-Singapore Suzhou Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
China-Singapore Suzhou Operational KPIs
China-Singapore Suzhou's Rule of 40 is 70% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
China-Singapore Suzhou's Rule of X is 88% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
China-Singapore Suzhou Competitors
China-Singapore Suzhou competitors include GIMV, Kinnevik, Georgia Capital, Antin Infrastructure Partners, Rocket Internet, Molten Ventures, Bure Equity, China Everbright, Fairfax India Holdings and Ratos.
Most China-Singapore Suzhou public comparables operate across PE & VC.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 6.0x | - | - | - | |||
| (5.1x) | - | (4.0x) | (15.0x) | |||
| 2.5x | - | - | - | |||
| 4.2x | 4.2x | 7.5x | 7.9x | |||
| 15.4x | - | 1.7x | - | |||
| 8.9x | 7.4x | 10.0x | 9.2x | |||
| 83.9x | - | (4.8x) | - | |||
| 23.0x | 10.2x | - | - | |||
This data is available for Pro users. Sign up to see all China-Singapore Suzhou competitors and their valuation data. Start Free Trial | ||||||
Investments by China-Singapore Suzhou
China-Singapore Suzhou has invested in 6 companies to date.
Latest investment by China-Singapore Suzhou was on August 31st 2026. China-Singapore Suzhou invested in Miwei Technology in their Series A round.
Latest Investments by China-Singapore Suzhou
| Description | Miwei Technology is a China-based developer of service-oriented intelligent computing systems, encompassing operating systems, edge computing, and cloud solutions. | Guoshun Laser is a Chinese developer of high-power ultrafast micro-nano structure fiber lasers. Guoshun Laser produces advanced laser systems for industrial and scientific applications. | Xiangzhi Technology is a developer of optoelectronic sensors including lidar and optical gyroscopes for multi-modal applications. | Ractigen Therapeutics is a San Francisco-headquartered biotech firm advancing RNA activation therapies to reactivate silenced genes in oncology and neurodegeneration. Its lead candidates target EZH2 and p21 genes using synthetic saRNAs delivered via lipid nanoparticles. Founded in 2016 from UCSF research, Ractigen advances clinical trials for liver cancer and holds patents on RNAa platforms licensed from the university. The pipeline includes programs for Alzheimer's partnered with academic labs. | |
| HQ Country | |||||
| HQ City | - | Suzhou | - | Nantong | |
| Deal Date | 31 Aug 2026 | 16 Mar 2026 | 24 Nov 2025 | 27 Jan 2022 | |
| Round | Series A | Series A | Seed | Series A | |
| Raised | undisclosed | undisclosed | undisclosed | $30M | |
| Investors | Matrix Partners China; Tsinghua Holdings Capital; Xinrui Capital; Broad Vision Funds; China-Singapore Suzhou; Yushi Space; Baidu Capital; Hillhouse Capital | Leadervc.com; Suzhou Angel Fund of Funds; China-Singapore Suzhou; DT Capital Partners; Honest Capital; Inovance; Oriza Holdings; Qianrong Venture Capital; Shanghai Electric Power Technology Fund; Oriza Seed Capital (Oriza Yuandian); Anxin Investment | China-Singapore Suzhou; Zhidao Capital | Xianghe Capital; China-Singapore Suzhou; Eisai Co.; Sino-Singapore Capital; LC Ventures; SDIC Venture Capital | |
| Valuation | undisclosed | undisclosed | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all China-Singapore Suzhou investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout China-Singapore Suzhou
| Who are competitors of China-Singapore Suzhou? | China-Singapore Suzhou main competitors include GIMV, Kinnevik, Georgia Capital, Antin Infrastructure Partners, Rocket Internet, Molten Ventures, Bure Equity, China Everbright, Fairfax India Holdings, Ratos. |
See public comps similar to China-Singapore Suzhou
Lists including China-Singapore Suzhou
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.





